Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Incyte patents novel GFMOs for cancer and fibrotic disorders

Feb. 3, 2000

Novel agent for treatment-refractory CIS now under review in Canada

Feb. 3, 2000

Telik initiates clinical testing of first development candidate

Feb. 3, 2000

Apoptotic and antibacterial cyclohexapeptide fungal metabolite discovered in Japan

Feb. 2, 2000

Improved anticancer anthracene derivatives designed at BTG

Feb. 2, 2000

Isis compounds modulate expression of antiapoptotic proteins A1 and mcl-1

Feb. 2, 2000

EntreMed to commence phase I trial of Angiostatin protein

Feb. 1, 2000

Kosan develops efficient production system for potent anticancer drugs

Feb. 1, 2000

Techniclone licenses novel antiangiogenic antibody

Feb. 1, 2000

Cell Pathways signs commercialization agreement for Aptosyn

Feb. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...